Literature DB >> 19875930

MicroRNA-125a represses cell growth by targeting HuR in breast cancer.

Xu Guo1, Yuehan Wu, Rebecca S Hartley.   

Abstract

MicroRNAs (miRNAs) are a class of naturally occurring, small, non-coding RNAs that control gene expression during development,normal cell function and disease. Although there is emerging evidence that some miRNAs can function as oncogenes or tumor suppressors, there is limited understanding of the role of miRNAs in cancer. In this study, we observed that the expression of miR-125a was inversely correlated with HuR expression in several different breast carcinoma cell lines. HuR is a stress-induced RNA binding protein whose expression is elevated or localization perturbed in several different cancers. Increased cytoplasmic localization of HuR is a prognostic marker in breast cancer. Real time PCR and gene reporter assays indicated that HuR was translationally repressed by miR-125a. Re-establishing miR-125a expression in breast cancer cells decreased HuR protein level and inhibited cell growth. Using MCF-7 breast cancer cells, we further clarified that miR-125a inhibited cell growth via a dramatic suppression of cell proliferation and promotion of apoptosis.In addition, cell migration was also inhibited by miR-125a overexpression. Importantly, the repression of cell proliferation and migration engendered by miR-125a was partly rescued by HuR re-expression. Our results suggest that miR-125a may function as a tumor suppressor for breast cancer, with HuR as a direct and functional target.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19875930      PMCID: PMC3645467          DOI: 10.4161/rna.6.5.10079

Source DB:  PubMed          Journal:  RNA Biol        ISSN: 1547-6286            Impact factor:   4.652


  57 in total

1.  Developmental biology. Encountering microRNAs in cell fate signaling.

Authors:  Xantha Karp; Victor Ambros
Journal:  Science       Date:  2005-11-25       Impact factor: 47.728

2.  Coordinate suppression of ERBB2 and ERBB3 by enforced expression of micro-RNA miR-125a or miR-125b.

Authors:  Gary K Scott; Andrei Goga; Dipa Bhaumik; Crystal E Berger; Christopher S Sullivan; Christopher C Benz
Journal:  J Biol Chem       Date:  2006-11-16       Impact factor: 5.157

3.  Mir-17-5p regulates breast cancer cell proliferation by inhibiting translation of AIB1 mRNA.

Authors:  Anwar Hossain; Macus T Kuo; Grady F Saunders
Journal:  Mol Cell Biol       Date:  2006-08-28       Impact factor: 4.272

4.  HuR contributes to cyclin E1 deregulation in MCF-7 breast cancer cells.

Authors:  Xun Guo; Rebecca S Hartley
Journal:  Cancer Res       Date:  2006-08-15       Impact factor: 12.701

5.  Downregulation of Bid is associated with PKCepsilon-mediated TRAIL resistance.

Authors:  U Sivaprasad; E Shankar; A Basu
Journal:  Cell Death Differ       Date:  2006-12-22       Impact factor: 15.828

6.  MicroRNA expression abnormalities in pancreatic endocrine and acinar tumors are associated with distinctive pathologic features and clinical behavior.

Authors:  Claudia Roldo; Edoardo Missiaglia; John P Hagan; Massimo Falconi; Paola Capelli; Samantha Bersani; George Adrian Calin; Stefano Volinia; Chang-Gong Liu; Aldo Scarpa; Carlo M Croce
Journal:  J Clin Oncol       Date:  2006-09-11       Impact factor: 44.544

7.  Cyclooxygenase-2 is an independent prognostic factor in gastric cancer and its expression is regulated by the messenger RNA stability factor HuR.

Authors:  Johanna Mrena; Jan-Patrik Wiksten; Alexandra Thiel; Arto Kokkola; Leena Pohjola; Johan Lundin; Stig Nordling; Ari Ristimäki; Caj Haglund
Journal:  Clin Cancer Res       Date:  2005-10-15       Impact factor: 12.531

8.  MicroRNA-21 is an antiapoptotic factor in human glioblastoma cells.

Authors:  Jennifer A Chan; Anna M Krichevsky; Kenneth S Kosik
Journal:  Cancer Res       Date:  2005-07-15       Impact factor: 12.701

9.  MicroRNA gene expression deregulation in human breast cancer.

Authors:  Marilena V Iorio; Manuela Ferracin; Chang-Gong Liu; Angelo Veronese; Riccardo Spizzo; Silvia Sabbioni; Eros Magri; Massimo Pedriali; Muller Fabbri; Manuela Campiglio; Sylvie Ménard; Juan P Palazzo; Anne Rosenberg; Piero Musiani; Stefano Volinia; Italo Nenci; George A Calin; Patrizia Querzoli; Massimo Negrini; Carlo M Croce
Journal:  Cancer Res       Date:  2005-08-15       Impact factor: 12.701

10.  A microRNA expression signature of human solid tumors defines cancer gene targets.

Authors:  Stefano Volinia; George A Calin; Chang-Gong Liu; Stefan Ambs; Amelia Cimmino; Fabio Petrocca; Rosa Visone; Marilena Iorio; Claudia Roldo; Manuela Ferracin; Robyn L Prueitt; Nozumu Yanaihara; Giovanni Lanza; Aldo Scarpa; Andrea Vecchione; Massimo Negrini; Curtis C Harris; Carlo M Croce
Journal:  Proc Natl Acad Sci U S A       Date:  2006-02-03       Impact factor: 11.205

View more
  92 in total

Review 1.  Micro-RNAs and breast cancer.

Authors:  John Le Quesne; Carlos Caldas
Journal:  Mol Oncol       Date:  2010-04-28       Impact factor: 6.603

Review 2.  Posttranscriptional regulation of cancer traits by HuR.

Authors:  Kotb Abdelmohsen; Myriam Gorospe
Journal:  Wiley Interdiscip Rev RNA       Date:  2010-05-06       Impact factor: 9.957

3.  The RNA-binding protein RNPC1 stabilizes the mRNA encoding the RNA-binding protein HuR and cooperates with HuR to suppress cell proliferation.

Authors:  Seong-Jun Cho; Yong-Sam Jung; Jin Zhang; Xinbin Chen
Journal:  J Biol Chem       Date:  2012-02-27       Impact factor: 5.157

4.  MicroRNA-125a inhibits cell growth by targeting glypican-4.

Authors:  Chao Feng; Jie Li; Jinlan Ruan; Kan Ding
Journal:  Glycoconj J       Date:  2012-05-27       Impact factor: 2.916

5.  Oncogenic potential of TSTA3 in breast cancer and its regulation by the tumor suppressors miR-125a-5p and miR-125b.

Authors:  Yanan Sun; Xiaohong Liu; Qingfu Zhang; Xiaoyun Mao; Liang Feng; Peng Su; Hao Chen; Yang Guo; Feng Jin
Journal:  Tumour Biol       Date:  2015-11-03

Review 6.  Recent trends in microRNA research into breast cancer with particular focus on the associations between microRNAs and intrinsic subtypes.

Authors:  Sasagu Kurozumi; Yuri Yamaguchi; Masafumi Kurosumi; Miki Ohira; Hiroshi Matsumoto; Jun Horiguchi
Journal:  J Hum Genet       Date:  2016-07-21       Impact factor: 3.172

7.  Post-transcriptional regulation of ERBB2 by miR26a/b and HuR confers resistance to tamoxifen in estrogen receptor-positive breast cancer cells.

Authors:  Sheng Tan; Keshuo Ding; Qing-Yun Chong; Junsong Zhao; Yuan Liu; Yunying Shao; Yuanyuan Zhang; Qing Yu; Zirui Xiong; Weijie Zhang; Min Zhang; Gaopeng Li; Xiaoni Li; Xiangjun Kong; Akhlaq Ahmad; Zhengsheng Wu; Qiang Wu; Xiaodong Zhao; Peter E Lobie; Tao Zhu
Journal:  J Biol Chem       Date:  2017-06-21       Impact factor: 5.157

Review 8.  The complex world of post-transcriptional mechanisms: is their deregulation a common link for diseases? Focus on ELAV-like RNA-binding proteins.

Authors:  Alessia Pascale; Stefano Govoni
Journal:  Cell Mol Life Sci       Date:  2011-09-10       Impact factor: 9.261

9.  MicroRNA-125a reduces proliferation and invasion of oral squamous cell carcinoma cells by targeting estrogen-related receptor α: implications for cancer therapeutics.

Authors:  Ankana Tiwari; Swamy Shivananda; Kodaganur S Gopinath; Arun Kumar
Journal:  J Biol Chem       Date:  2014-09-29       Impact factor: 5.157

10.  Prognostic marker microRNA-125b inhibits tumorigenic properties of hepatocellular carcinoma cells via suppressing tumorigenic molecule eIF5A2.

Authors:  Felice H Tsang; Victor Au; Wen-Jing Lu; Felix H Shek; Angela M Liu; John M Luk; Sheung-Tat Fan; Ronnie T P Poon; Nikki P Lee
Journal:  Dig Dis Sci       Date:  2014-05-09       Impact factor: 3.199

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.